Ironwood Pharmaceuticals
IRWD
#6415
Rank
A$1.14 B
Marketcap
A$7.02
Share price
0.62%
Change (1 day)
84.38%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2025 (TTM): A$0.14 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are A$0.33 Billion. In 2024 the company made an earning of A$93.62 Million, an increase over its 2023 earnings that were of -A$1.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.14 B50.45%
2024 A$93.62 M-106.88%
2023 -A$1.37 Billion-475.59%
2022 A$0.36 B25.8%
2021 A$0.28 B84.32%
2020 A$0.15 B84.69%
2019 A$84.64 M-125.13%
2018 -A$0.34 Billion100.62%
2017 -A$0.17 Billion43.12%
2016 -A$0.12 Billion-42.73%
2015 -A$0.21 Billion-24.76%
2014 -A$0.28 Billion-30.49%
2013 -A$0.4 Billion275.65%
2012 -A$0.11 Billion11.56%
2011 -A$93.49 Million9.38%
2010 -A$85.47 Million-15.21%
2009 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
A$18.79 B 13,890.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Nektar Therapeutics
NKTR
-A$0.17 Billion-221.61%๐Ÿ‡บ๐Ÿ‡ธ USA